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Introduction
Childhood-onset systemic lupus erythematosus (cSLE)
have a high prevalence cognitive involvement and inflam-
matory mechanisms and autoantibodies were hypothesized
to be involved in its pathogenesis. The underlying factor
for an association between the metabolic syndrome
(MetS) and cognitive decline might be a subclinical
inflammation.
Objectives
To determine if cognitive functions are impaired in
cSLE patients with MetS.
Methods
We performed a cross sectional study of 63 consecutive
cSLE patients and 63 healthy age and sex matched con-
trols. All individuals were assessed for anthropometric
and MetS features according to International Diabetes
Federation (IDF) criteria. Neurological manifestations
were analyzed according to the ACR classification cri-
teria. Cognitive evaluation was performed in all partici-
pants using Wechsler Intelligence Scale for children
(WISC-III) and Wechsler Intelligence Scale for adults
(WAIS), according to age and validated in Portuguese.
Mood disorders were determined through Becks Depres-
sion and Anxiety Inventory in all participants. SLE
patients were further assessed for clinical and laboratory
SLE manifestations, disease activity [SLE Disease Activity
Index (SLEDAI)], damage [Systemic Lupus International
Collaborating Clinics/American College of Rheumatology
Damage Index (SDI)] and current drug exposures. Total
dose of corticosteroids and other immunosuppressant
medications used since the onset of disease were calcu-
lated by data obtained by careful review of the medical
charts.
Results
We observed higher hip circumference (p=0.030), waist-to-
hip ratio (p<0.001) and hypertriglyceridemia (p=0.005) in
cSLE patients. Controls had a higher height (p=0.003) and
higher levels of HDL-c (p=0.004). MetS was present in
11 (17.4%) cSLE and in no control. Cognitive dysfunction
was observed in 32 (50.8%) cSLE patients. We observed an
inverse correlation with height and corticosteroid total dose
adjusted by weight in cSLE patients (-0.285; p=0.022). Rey
complex picture on memory subtest was correlated with
body mass index (r=-0.249; p=0.05) and hypertriglyceride-
mia (r=0.282;p=0.028). Total cholesterol levels was corre-
lated with Boston naming test (r=-0.258; p=0.047).
Conclusion
MetS was observed in 18% of our cohort and not associated
with worse cognitive performance. However, features of
MetS, such as total cholesterol, hypertriglyceridemia and
obesity can influence some cognitive functions in cSLE.
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